These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18382463)

  • 1. Defining drug disposition determinants: a pharmacogenetic-pharmacokinetic strategy.
    Katz DA; Murray B; Bhathena A; Sahelijo L
    Nat Rev Drug Discov; 2008 Apr; 7(4):293-305. PubMed ID: 18382463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG.
    Brian W; Tremaine LM; Arefayene M; de Kanter R; Evers R; Guo Y; Kalabus J; Lin W; Loi CM; Xiao G
    Pharmacogenomics; 2016 Apr; 17(6):615-31. PubMed ID: 27045656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.
    Mooij MG; Nies AT; Knibbe CA; Schaeffeler E; Tibboel D; Schwab M; de Wildt SN
    Clin Pharmacokinet; 2016 May; 55(5):507-24. PubMed ID: 26410689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of genetic polymorphism in drug metabolism in the development of new drugs.
    Balant LP; Gundert-Remy U; Boobis AR; von Bahr C
    Eur J Clin Pharmacol; 1989; 36(6):551-4. PubMed ID: 2673794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.
    Masimirembwa CM; Bredberg U; Andersson TB
    Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered disposition of drugs in acute renal failure rat models: drug development strategies and perspectives.
    Srinivas NR
    Arzneimittelforschung; 2010; 60(12):731-48. PubMed ID: 21265465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An algorithm for evaluating potential tissue drug distribution in toxicology studies from readily available pharmacokinetic parameters.
    Poulin P; Dambach DM; Hartley DH; Ford K; Theil FP; Harstad E; Halladay J; Choo E; Boggs J; Liederer BM; Dean B; Diaz D
    J Pharm Sci; 2013 Oct; 102(10):3816-29. PubMed ID: 23878104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacogenomics: the quest for individualized therapy].
    López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
    Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What do we know about the drug metabolism?].
    Pelkonen O; Raunio H
    Duodecim; 1998; 114(10):971-7. PubMed ID: 11524785
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacogenetics: pharmacokinetics and clinical implications].
    Blardi P
    Recenti Prog Med; 1997 Jan; 88(1):46-55. PubMed ID: 9102716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New directions in pharmacogenetics: Introduction.
    Vesell ES
    Fed Proc; 1984 May; 43(8):2319-25. PubMed ID: 6714440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic drug metabolism in cystic fibrosis: recent developments and future directions.
    Kearns GL
    Ann Pharmacother; 1993 Jan; 27(1):74-9. PubMed ID: 8431626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics in drug discovery and development: a translational perspective.
    Roses AD
    Nat Rev Drug Discov; 2008 Oct; 7(10):807-17. PubMed ID: 18806753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic factors in drug metabolism.
    Belle DJ; Singh H
    Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symposium "Clinical Pharmacology Anno 2008". 10th Heymans Memorial Lecture.
    Van Bortel L
    Verh K Acad Geneeskd Belg; 2009; 71(6):315-34. PubMed ID: 20232787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacogenetics or the promise of a personalized medicine: variability in drug metabolism and transport].
    Allorge D; Loriot MA
    Ann Biol Clin (Paris); 2004; 62(5):499-511. PubMed ID: 15355800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging siRNA Design Principles and Consequences for Biotransformation and Disposition in Drug Development.
    Humphreys SC; Thayer MB; Campbell J; Chen WLK; Adams D; Lade JM; Rock BM
    J Med Chem; 2020 Jun; 63(12):6407-6422. PubMed ID: 32352779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual differences in the disposition of drugs metabolised in the body.
    Alvan G
    Clin Pharmacokinet; 1978; 3(2):155-75. PubMed ID: 346288
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacogenetics and the concept of individualized medicine.
    Shastry BS
    Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of target-mediated drug disposition for small molecules.
    Smith DA; van Waterschoot RAB; Parrott NJ; Olivares-Morales A; Lavé T; Rowland M
    Drug Discov Today; 2018 Dec; 23(12):2023-2030. PubMed ID: 29928850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.